07/10/2017 Reven News Press

Reven selected an Australian Contract Manufacturing Organization (CMO) to supply drug product for Phase I Clinical Trial

07/10/2017 Reven News Press2020-01-20T21:55:04-05:00

2017/07/10 Reven News Press

Reven selected an Australian Contract Manufacturing Organization (CMO) to supply drug product for Phase I Clinical Trial.

2017/07/10 Reven News Press2020-01-22T11:20:04-05:00

06/12/2017 Reven News Press

The US Patent and Trademark Office (USPTO) allowed Reven RJX Family One Child Patent, application # 14,550,677. This is our "method of treating” patent.

06/12/2017 Reven News Press2017-12-02T16:20:09-05:00